Byberg, Sarah
Abrahamsen, Bo
Kassem, Moustapha
Ralston, Stuart
Schwarz, Peter http://orcid.org/0000-0002-0483-8594
Article History
Received: 16 March 2018
Accepted: 28 August 2018
First Online: 27 September 2018
Ethics approval and consent to participate
: The Danish Health Authority was informed of the off label use of denosumab as treatment in this case.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.